ŌURA launches its first proprietary AI model for women’s health
ŌURA said the launch comes as more people turn to AI tools for health information.
ŌURA, the company behind the Oura Ring wearable device, has launched its first proprietary artificial intelligence model designed specifically for women’s health.
The model will sit with Oura Advisor which is part of Oura’s companion app and is an AI-powered tool which allows members to ask questions about their health data and receive guidance in plain language.
Until now that guidance from Oura Advisor has relied in part on general purpose AI systems. The new model, which is being rolled out for testing in Oura Labs, has been built specifically for women’s health. It draws on established medical standards, research and knowledge sources reviewed by ŌURA’s in-house team of board-certified clinicians and women’s health experts. It also incorporates members’ biometric data and long-term trends to provide personalised guidance.
The company said the system supports questions across the reproductive lifespan, from early menstrual cycles to menopause. It has been tailored to reflect women’s physiology and health experiences, marking a shift away from relying solely on general-purpose AI tools.
“This custom model is a fundamental shift in how we responsibly deploy AI in health to meet the needs of our members,” said Ricky Bloomfield, MD, chief medical officer at ŌURA.
“Women’s health is too complex—and too often overlooked—to rely on one-size-fits-all systems. By designing a model specifically for women and grounding it in trusted clinical science and real-world biometric data, we’re setting the standard for how responsible intelligence should be built and expanded across more areas of health, pairing rigorous science with the lived, longitudinal data that makes ŌURA uniquely powerful.”
Growing use of AI for health information
ŌURA said the launch comes as more people turn to AI tools for health information. Citing a 2025 survey, the company said nearly eight in 10 adults in the US look up health symptoms or conditions online, and almost two-thirds report seeing AI-generated responses in their results.
There is also a growing need for models that are clinically grounded and designed specifically around women’s health. Earlier this year, a dedicated women’s health study by Lumos and academic partners tested 13 large language models across 96 women’s health scenarios, finding a 60% failure rate. Separately, a Guardian investigation found Google AI Overviews providing misleading health advice, including incorrectly describing Pap tests as diagnostics for vaginal cancer — and returning inconsistent answers to identical searches. Google maintains that the “vast majority” of responses are accurate.
The new ŌURA model builds on Oura Advisor’s existing use of generative AI and health-sensing algorithms. When a member asks a women’s health question, the system references a curated body of research and knowledge sources while analysing relevant biometric signals and long-term trends across sleep, activity, cycle and pregnancy data, stress and other metrics.
ŌURA said the model has been tuned to be non-dismissive and emotionally supportive. It is intended to help members prepare for conversations with healthcare providers rather than replace clinical care.
“Women’s health questions are often deeply personal and high-stakes, and they deserve answers that can be trusted,” said Chris Curry, MD, clinical director of women’s health at ŌURA and a board-certified OB/GYN.
“With this model, we’re providing the kind of preparation and insight that I wish every one of my patients had before coming to their appointment. For example, if someone asks, ‘Why has my cycle suddenly become irregular, and is that something to worry about?’ Oura Advisor can walk them through what’s typical, what their data may be showing, and what would be most helpful to surface in conversations with their provider. It translates complex science into clear, compassionate, always-available guidance—helping women connect what they’re feeling with what they’re seeing in their data, and allowing them to walk into discussions about their health more informed, confident, and in control of their decisions.”
ŌURA said the Oura Ring is not a medical device and is not intended to diagnose, treat, cure, monitor or prevent medical conditions or illnesses.
Privacy and testing
The company said the model is hosted on ŌURA-controlled infrastructure and that conversations are not shared or sold. It described the system as part of its “privacy-first” approach to AI.
Participation in Oura Labs is optional. Members can choose to test the new model or opt out at any time. According to the company, Oura Labs is used to evaluate new features in partnership with members before they are integrated into the main app, refined further or removed.
ŌURA said its clinical and technical teams developed the women’s health model using knowledge-graph technology from webAI. The company said it is working with webAI to develop what it describes as a privacy-first architecture focused on performance and user experience.
Founded in Finland in 2013, ŌURA has headquarters in Oulu and San Francisco. The company says the Oura Ring tracks more than 50 health metrics and is used by millions of members worldwide. In recent years it has increased its focus on women’s health, particularly through integrations and partnerships such as with Maven Clinic It was last valued at approximately $11bn following a $900m raise, making it one of the most highly valued standalone wearable firms.